Skip to main content
NewslettersWatchlist

Intercure Ltd(INCR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.63
Day High2.69
Open:2.69
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
InterCure Provides an Update Regarding Nir Oz Facility
GlobeNewswire
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
GlobeNewswire
InterCure Wins Cannolam Arbitration Proceeding
GlobeNewswire
InterCure Provides an Update Regarding the Security Situation in Israel
GlobeNewswire
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
GlobeNewswire
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
GlobeNewswire
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
Business Wire
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
Globe Newswire
InterCure to Release its Q2 2022 Results and Hold a Conference Call
Globe Newswire
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth
Globe Newswire
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
Globe Newswire
InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel
Globe Newswire
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
Globe Newswire
InterCure to Release its Q1 2022 Results and Hold a Conference Call
Globe Newswire
InterCure to Participate in Upcoming Investor Conferences in May 2022
Globe Newswire
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
Globe Newswire
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results
Globe Newswire
InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022
Globe Newswire
CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
Globe Newswire
InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
Globe Newswire
InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
Globe Newswire
InterCure and Clever Leaves Announce International Strategic Partnership
Globe Newswire
InterCure to Participate in ROTH Capital’s 34th Annual Conference
Globe Newswire
InterCure Announces Partnership with Altman Health
Globe Newswire
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
Globe Newswire
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
Globe Newswire
InterCure Announces European Expansion with International Cannabis Brand Cookies
Business Wire
International Cannabis Brand Cookies and InterCure Announce European Expansion
Globe Newswire
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
Globe Newswire
InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth
Globe Newswire
InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month
Globe Newswire
InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth

Profile

InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.